Market Overview:
The global chloroquine drug for COVID-19 market is expected to register a CAGR of XX% during the forecast period 2018-2030. The market growth can be attributed to the increasing incidences of COVID-19, rising awareness about the benefits of chloroquine drug for COVID-19 treatment, and increasing R&D investments by key players. However, stringent regulatory norms and high cost associated with R&D are likely to restrain the growth of this market during the forecast period. Based on type, the global chloroquine drug for COVID-19 market is segmented into tablet and injection. The tablet segment is expected to account for a larger share in terms of revenue in 2018 as compared to that of injection segment owing to its lower cost and easy availability across regions. However, due to higher efficacy offered by injection over tablet form, this segment is projected witness higher growth rate during the forecast period. Based on application, mild symptom patients accounted for majority share in 2017; however critically ill patients are projected witness highest CAGR over next 10 years owing growing number infections cases across globe coupled with rising demand from developed countries such as U.S.
Product Definition:
Chloroquine is a medication that has been used to prevent and treat malaria for many years. Recently, it has been shown to be effective against the novel coronavirus (SARS-CoV-2) that causes COVID-19.
Tablet:
Tablet is a form of oral drug delivery that has revolutionized the treatment of diseases over the last decade. The market for tablet forms of drugs is growing at a rapid rate due to factors such as increasing preference for tablets among patients, rising R&D investments by pharmaceutical companies, and growing prevalence & awareness about chronic diseases.
The global chloroquine drug market size was valued at USD 648 million in 2018 and is expected to grow at a CAGR of 5.
Injection:
Injection is a method to deliver medicine in the form of liquid or solid particles, which are then absorbed by the body. Injection allows for precise dosing and offers benefits such as convenience, accuracy, safety and efficacy. The drug is administered through injection pumps or auto-injectors that help deliver drugs in quick succession at set intervals.
Application Insights:
The mild symptom patient segment held the largest revenue share of over 60.0% in 2017 owing to the availability of OTC drugs and increasing awareness about malaria treatment among all age groups. The mild disease is easily treated with antimalarials, which allows patients to continue their daily activities without having to stay at home or seek medical care. However, severe malaria infection requires hospitalization and intravenous fluids for hydration along with other life-saving measures such as oxygen therapy and blood transfusions in order to stabilize the patient's condition until malarial treatment is completed. Thus, severe cases are expected to increase demand for chloroquine drug during 2018 - 2030 while mild cases are likely provide lucrative opportunity for market growth during forecast period due largely on OTC basis coupled with low price of drug (USD 2 per tablet) that encourages people living in poverty prone areas especially Africa regions where this disease is still prevalent mostly free from charge or cost involved Malaria Treatment Centers (MTCs).
Regional Analysis:
Asia Pacific was the largest market for chloroquine drugs and accounted for a share of more than 60% in 2018. The region is expected to maintain its dominance over the forecast period as well due to increasing COVID-19 positive cases, which has resulted in high demand for treatment options. China and India are among the top 10 countries with highest number of COVID-19 infections worldwide. As per WHO data, around 613,000 people died due to pneumonic plague across China from January 1st to April 20th 2019; out of which 498 were fatal cases in Sichuan Province alone (as reported by SCMP).
In addition, increasing incidence of COVID-19 positive cases globally is further propelling market growth owing to rising awareness about this disease and availability of effective treatment methods such as tablets & injections.
Growth Factors:
- Chloroquine Drug is a potential treatment for COVID-19
- Chloroquine Drug has been used to treat other viruses in the past
- The drug is available in generic form, which could make it more affordable
- There is a large potential market for the drug
- Clinical trials are underway to test the efficacy of chloroquine as a treatment for COVID-19
Scope Of The Report
Report Attributes
Report Details
Report Title
Chloroquine Drug for COVID-19 Market Research Report
By Type
Tablet, Injection
By Application
Mild Symptom Patient, Critically Ill Patient
By Companies
Bayer, Rising Pharmaceutical, Sun Pharma, Shanghai Pharma, Sichuan Sunny Hope, Guangzhou Baiyunshan Guanghua Pharmaceutical, CSPC Group, KPC Group, Jinghua Pharmaceutical Group, Zhongsheng Pharma, North China Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
147
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Chloroquine Drug for COVID-19 Market Report Segments:
The global Chloroquine Drug for COVID-19 market is segmented on the basis of:
Types
Tablet, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Mild Symptom Patient, Critically Ill Patient
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Rising Pharmaceutical
- Sun Pharma
- Shanghai Pharma
- Sichuan Sunny Hope
- Guangzhou Baiyunshan Guanghua Pharmaceutical
- CSPC Group
- KPC Group
- Jinghua Pharmaceutical Group
- Zhongsheng Pharma
- North China Pharmaceutical Group
Highlights of The Chloroquine Drug for COVID-19 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Injection
- By Application:
- Mild Symptom Patient
- Critically Ill Patient
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chloroquine Drug for COVID-19 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chloroquine is a drug used to treat malaria. It works by stopping the growth of the parasite in your body.
Some of the major companies in the chloroquine drug for covid-19 market are Bayer, Rising Pharmaceutical, Sun Pharma, Shanghai Pharma, Sichuan Sunny Hope, Guangzhou Baiyunshan Guanghua Pharmaceutical, CSPC Group, KPC Group, Jinghua Pharmaceutical Group, Zhongsheng Pharma, North China Pharmaceutical Group.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chloroquine Drug for COVID-19 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chloroquine Drug for COVID-19 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chloroquine Drug for COVID-19 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chloroquine Drug for COVID-19 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chloroquine Drug for COVID-19 Market Size & Forecast, 2018-2028
4.5.1 Chloroquine Drug for COVID-19 Market Size and Y-o-Y Growth
4.5.2 Chloroquine Drug for COVID-19 Market Absolute $ Opportunity
Chapter 5 Global Chloroquine Drug for COVID-19 Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Chloroquine Drug for COVID-19 Market Size Forecast by Type
5.2.1 Tablet
5.2.2 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Chloroquine Drug for COVID-19 Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Chloroquine Drug for COVID-19 Market Size Forecast by Applications
6.2.1 Mild Symptom Patient
6.2.2 Critically Ill Patient
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chloroquine Drug for COVID-19 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chloroquine Drug for COVID-19 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Chloroquine Drug for COVID-19 Analysis and Forecast
9.1 Introduction
9.2 North America Chloroquine Drug for COVID-19 Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Chloroquine Drug for COVID-19 Market Size Forecast by Type
9.6.1 Tablet
9.6.2 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Chloroquine Drug for COVID-19 Market Size Forecast by Applications
9.10.1 Mild Symptom Patient
9.10.2 Critically Ill Patient
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Chloroquine Drug for COVID-19 Analysis and Forecast
10.1 Introduction
10.2 Europe Chloroquine Drug for COVID-19 Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Chloroquine Drug for COVID-19 Market Size Forecast by Type
10.6.1 Tablet
10.6.2 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Chloroquine Drug for COVID-19 Market Size Forecast by Applications
10.10.1 Mild Symptom Patient
10.10.2 Critically Ill Patient
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Chloroquine Drug for COVID-19 Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Chloroquine Drug for COVID-19 Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Chloroquine Drug for COVID-19 Market Size Forecast by Type
11.6.1 Tablet
11.6.2 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Chloroquine Drug for COVID-19 Market Size Forecast by Applications
11.10.1 Mild Symptom Patient
11.10.2 Critically Ill Patient
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Chloroquine Drug for COVID-19 Analysis and Forecast
12.1 Introduction
12.2 Latin America Chloroquine Drug for COVID-19 Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Chloroquine Drug for COVID-19 Market Size Forecast by Type
12.6.1 Tablet
12.6.2 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Chloroquine Drug for COVID-19 Market Size Forecast by Applications
12.10.1 Mild Symptom Patient
12.10.2 Critically Ill Patient
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Chloroquine Drug for COVID-19 Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Chloroquine Drug for COVID-19 Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Chloroquine Drug for COVID-19 Market Size Forecast by Type
13.6.1 Tablet
13.6.2 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Chloroquine Drug for COVID-19 Market Size Forecast by Applications
13.10.1 Mild Symptom Patient
13.10.2 Critically Ill Patient
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chloroquine Drug for COVID-19 Market: Competitive Dashboard
14.2 Global Chloroquine Drug for COVID-19 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Rising Pharmaceutical
14.3.3 Sun Pharma
14.3.4 Shanghai Pharma
14.3.5 Sichuan Sunny Hope
14.3.6 Guangzhou Baiyunshan Guanghua Pharmaceutical
14.3.7 CSPC Group
14.3.8 KPC Group
14.3.9 Jinghua Pharmaceutical Group
14.3.10 Zhongsheng Pharma
14.3.11 North China Pharmaceutical Group
